Clinical trial sites are burdened by pass-through costs, which are not fully reimbursed, leading to financial strain. The process of invoicing for these costs is time-consuming and often results in delayed or unreceived payments, causing additional administrative and financing expenses for the site. This impacts the site's operations, staff resources, and overall financial well-being.
Clinical trial invoicing can be optimized with early invoicing, adherence to contract specifications, building relationships, setting reminders, and persistence. Deviating from contract instructions can lead to delayed payments.
It's time for clinical trial sponsors and CROs to recognize that sites should be compensated for monitoring visits. Sites are increasingly asked to do more in clinical trials and the study budgets haven't increased with the additional responsibilities.
Clinical Research 